Clinical Trials Directory

Trials / Unknown

UnknownNCT06160869

Effect of Acceptance and Commitment Therapy on Psychotic Severity

Efficacy of Acceptance and Commitment Therapy on Psychotic Severity Among Inpatients With Primary Psychosis: A Randomized Controlled Trial.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
76 (estimated)
Sponsor
Port Said University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Our study aims to assess the efficacy of Acceptance and Commitment Therapy on psychotic severity among Inpatients with primary psychosis: A Randomized Controlled Trial.

Detailed description

Current study was an open label, two-arm, parallel, randomized controlled trial, evaluating the efficiency of Acceptance and Commitment Therapy (ACT) added to treatment as usual (TAU) as opposed to treatment as usual (TAU) alone on patients with schizophrenia. The study adheres to the rules for writing Clinical Trials: "The Consolidated Standards of Reporting Trials" (CONSORT) statement

Conditions

Interventions

TypeNameDescription
BEHAVIORALAcceptance and commitment therapyThe psychoeducational intervention will consist of seven structured sessions aimed at introducing patients with primary psychosis to the principles and practices of Acceptance and Commitment Therapy (ACT). The primary focus of the intervention is to empower participants to effectively manage distressing thoughts and feelings while pursuing meaningful and valued life goals. Each session covers specific aspects of ACT. Acceptance and commitment therapy will be adminitered in addition to treament as usual provided to patients.
COMBINATION_PRODUCTTreatment as usualThe treatment as usual (TAU) for all patients regardless of condition will consist of hospital treatment, including daily medication management sessions with a psychiatrist (e.g., antipsychotic and other medications as appropriate), community meetings, other group therapy, case management, occupational therapy, open air walks, discharge planning, physical examination, and other services (e.g., medical testing).

Timeline

Start date
2023-10-01
Primary completion
2023-12-01
Completion
2023-12-20
First posted
2023-12-07
Last updated
2023-12-07

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06160869. Inclusion in this directory is not an endorsement.